PT3768304T - Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins - Google Patents

Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins

Info

Publication number
PT3768304T
PT3768304T PT197403843T PT19740384T PT3768304T PT 3768304 T PT3768304 T PT 3768304T PT 197403843 T PT197403843 T PT 197403843T PT 19740384 T PT19740384 T PT 19740384T PT 3768304 T PT3768304 T PT 3768304T
Authority
PT
Portugal
Prior art keywords
immunoglobulins
compositions
increasing
reducing
methods
Prior art date
Application number
PT197403843T
Other languages
Portuguese (pt)
Original Assignee
Inst Nat Sante Rech Med
Genethon
Univ Sorbonne
Spark Therapeutics Inc
Univ Paris Cite
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Genethon, Univ Sorbonne, Spark Therapeutics Inc, Univ Paris Cite filed Critical Inst Nat Sante Rech Med
Publication of PT3768304T publication Critical patent/PT3768304T/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
PT197403843T 2018-07-17 2019-07-17 Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins PT3768304T (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18305971 2018-07-17

Publications (1)

Publication Number Publication Date
PT3768304T true PT3768304T (en) 2023-01-13

Family

ID=63678571

Family Applications (1)

Application Number Title Priority Date Filing Date
PT197403843T PT3768304T (en) 2018-07-17 2019-07-17 Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins

Country Status (1)

Country Link
PT (1) PT3768304T (en)

Similar Documents

Publication Publication Date Title
ZA202100202B (en) Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins
ZA201902968B (en) Method for increasing the secretion levels of interleukin 2 and proteins derived from it
SG11202103033WA (en) Compositions and methods for the treatment of presbyopia
SG11202106585UA (en) Polishing compositions and methods of using same
IL290792A (en) Compositions and methods for the treatment of viral infections
EP3833340A4 (en) Compositions and methods for treatment of presbyopia
SG11202011151VA (en) Compositions and methods for reducing spliceopathy and treating rna dominance disorders
SG11202106584QA (en) Polishing compositions and methods of using same
SG11202104053TA (en) Compositions and methods for the treatment of estrogen-dependent disorders
IL284480A (en) Composition and methods for treatment of primary ciliary dyskinesia
IL286040A (en) Methods of treating al amyloidosis
IL292678A (en) Methods of treating depressive disorders
EP4093436A4 (en) Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins
IL278978A (en) Compositions and methods for treatment of psoriasis
PT3768304T (en) Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins
IL287250A (en) Method of treatment
EP4054606A4 (en) Use of mbv for treating autoimmune diseae
GB201810923D0 (en) Compositions and method of treatment
GB201907305D0 (en) Treatment of conditions
IL291192A (en) Compositions and methods of treating lupus nephritis
GB201913114D0 (en) Targeted sequencing of y-chromosome
IL289824A (en) Methods of treating multiple sclerosis
IL290983A (en) Methods of treatment
IL277988A (en) Compositions and methods for treatment of demyelination
GB201901219D0 (en) Compositions and methods of treatment